Detalhe da pesquisa
1.
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 71(7): e31051, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38706187
2.
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 71(7): e31039, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38689540
3.
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Pediatr Blood Cancer
; : e31089, 2024 May 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38822537
4.
Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatr Blood Cancer
; 70(2): e30054, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36316811
5.
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
Pediatr Blood Cancer
; 70 Suppl 6: e30572, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37458162
6.
Topotecan clearance based on a single sample and a population pharmacokinetic model: Application to a pediatric high-risk neuroblastoma clinical trial.
Pediatr Blood Cancer
; 70(11): e30658, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37664968
7.
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 70(8): e30418, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37199022
8.
Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatr Blood Cancer
; 69(9): e29616, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35188340
9.
Expression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapy.
Pediatr Blood Cancer
; 69(9): e29719, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35441784
10.
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.
Pediatr Blood Cancer
; 68(10): e29117, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34028986
11.
The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma.
Pediatr Blood Cancer
; 67(1): e28031, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31612589
12.
Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma.
J Pediatr Hematol Oncol
; 41(3): 222-227, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30334904
13.
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.
JAMA
; 322(8): 746-755, 2019 08 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31454045
14.
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.
Eur J Nucl Med Mol Imaging
; 45(2): 292-305, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28940046
15.
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Lancet Oncol
; 18(7): 946-957, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28549783
16.
Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.
Cancer
; 123(24): 4914-4923, 2017 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28885700
17.
Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Cancer
; 123(21): 4224-4235, 2017 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28696504
18.
Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
Am J Pathol
; 186(11): 3040-3053, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27743558
19.
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 64(11)2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28383813
20.
A family-based study of gene variants and maternal folate and choline in neuroblastoma: a report from the Children's Oncology Group.
Cancer Causes Control
; 27(10): 1209-18, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27541142